Last update 20 Mar 2025

NTx 265

Overview

Basic Info

Drug Type
Recombinant protein
Synonyms
BetahCG + EPO, NTx265 regimen, bhCG + EPO
+ [3]
Target-
Action
stimulants
Mechanism
Cell differentiation stimulants, Erythropoiesis stimulants(Erythropoiesis stimulants), Ovarian follicle stimulants
Therapeutic Areas
Nervous System DiseasesCardiovascular DiseasesOther Diseases
Active Indication-
Inactive Indication
Acute Ischemic StrokeBrain Injuries, Traumatic
Originator Organization
Stem Cell Therapeutics
Active Organization-
Inactive Organization
Stem Cell Therapeutics
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with NTx 265
NCT01239706
/ Unknown statusPhase 2IIT
A Phase IIa, Single Centre, Open Label Study to Characterize the Safety of Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Traumatic Brain Injury: Dosing Tier 1
NCT00715364
/ WithdrawnPhase 2
A Phase IIb Prospective, Randomized, Double-blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients
NCT00663416
/ TerminatedPhase 2
A Phase IIb Prospective, Randomized, Double-blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS)
100 Clinical Results associated with NTx 265
Login to view more data
100 Translational Medicine associated with NTx 265
Login to view more data
100 Patents (Medical) associated with NTx 265
Login to view more data
100 Deals associated with NTx 265
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Brain Injuries, TraumaticPhase 2
Canada
Stem Cell Therapeutics
01 Nov 2010
Acute Ischemic StrokePhase 2
Canada
Stem Cell Therapeutics
01 Mar 2008
Acute Ischemic StrokePhase 2
India
Stem Cell Therapeutics
01 Mar 2008
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free